| Structure | Chemical Name | CAS | MF |
|
OMEPRAZOLE + DOMPERIDONE
|
|
|
|
|
Omeprazole, magnesium salt
|
|
|
|
Omeprazole magnesium
|
95382-33-5
|
C34H36MgN6O6S2
|
|
|
OMEPRAZOLE ENTERIC COATED PELLETS
|
|
|
|
Omeprazole
|
|
C17H19N3O3S
|
|
OMEPRAZOLE-D3 SULFONE
|
1189891-71-1
|
C17H16D3N3O5S
|
|
OMEPRAZOLE POWDER
|
|
C17H19N3O3S
|
|
OMEPRAZOLE RELATED COMPOUND A (15 MG) (OMEPRAZOLE SULFONE) (AS)
|
88546-55-8
|
C17H19N3O4S
|
|
OMEPRAZOLE-D3 SULFIDE
|
922730-98-1
|
C17H16D3N3O3S2
|
|
OMEPRAZOLE
|
|
C17H19N3O3S
|
|
|
Omeprazole-5-Methoxy-2[[(4-Methoxy-3,5-Dimethyl-2-Pyridinyl)Methyl]Sulfinyl]-1H-Benzimidazole
|
|
|
|
|
Omeprazole(Prilosec)Powder
|
|
|
|
OMEPRAZOLE-D3 (BENZIMIDAZOLE-4,6,7-D3)
|
|
C17H16D3N3O3S
|
|
|
2'O-Me-rA(bz) Phosphoramidite
|
|
|
|
|
2'O-Me-rA(bz) CPG500 ,30 - 40μmol/g
|
|
|
|
|
2'O-Me-rA(bz) CPG500
|
|
|
|
|
o-MercatobenzoicAcid
|
|
|
|
|
2'O-Me-rC(tac) Phosphoramidite
|
|
|
|
|
O-(2-(3-MERCAPTOPROPIONYLAMINO)ETHYL)- O-'METHYL-PEG 5'000
|
|
|
|
|
2'O-Me-rC(tac) CPG500 ,30 - 40μmol/g
|
|
|
|
o-mercapto-N,N-dimethylbenzamide
|
20877-02-5
|
C9H11NOS
|
|
3'-O-L-phenylalanyladenosine
|
5956-81-0
|
C19H22N6O5
|
|
2'-O-L-phenylalanyladenosine
|
26545-82-4
|
|
|
|
2'O-Me-rG(ib) CPG500 ,30 - 40μmol/g
|
|
|
|
|
2'O-Me-rG(ib) CPG500
|
|
|
|
|
2'O-Me-rG(ib) Phosphoramidite
|
|
|
|
|
Omesartan CS-866
|
|
|
|
|
2'-O-MERNA
|
|
|
|
Omerprazole magnesium
|
|
C17H19MgN3O3S
|
|
o-Mesitylenesulfonyl HydroxylaMine
|
58042-39-0
|
C9H13NO3S
|
|
O-mesitoyl N-benzyloxycarbonylphenylalanyl-glycine hydroxamate
|
118292-30-1
|
C29H31N3O6
|
|
O-Mesitylenesulfonylhydroxylamine
|
36016-40-7
|
C9H13NO3S
|
|
|
2'O-Me-rU CPG500
|
|
|
|
|
2'O-Me-rU Phosphoramidite
|
|
|
|
|
2'O-Me-rU CPG500 ,30 - 40μmol/g
|
|
|
|
Olpimedone
|
39567-20-9
|
C7H10N2OS
|
|
|
OKY-046·sodium
|
|
|
|
2'-O-Methyl-N2-Isobutyryl-5'-O-DMT-Guanosine
|
1239669-73-8
|
C36H39N5O8
|
|
|
2'-O-Methyl-N6-Benzoyl-5'-O-DMT-Adenosine
|
|
|
|
|
2'-O-Methyl-5'-O-DMT-Uridine
|
|
|
|
|
2'-O-Methyl-N4-Acetyl-5'-O-DMT-Cytidine
|
|
|
|
|
2'-O-Methyl-2,6-diaminopurine-riboside
|
|
|
|
|
2'-O-Methyl-N2-dimethylformamide-5'-O-DMT-Guanosine
|
|
|
|
|
2'-O-Methyl-5'-O-DMT-Inosine
|
|
|
|
|
2'-O-Methyl-N4-Benzoyl-5'-O-DMT-Cytidine
|
|
|
|
O-methyl 3-β-hydroxy-5-spirostene
|
116292-24-1
|
C28H44O3
|
|
O-Methyl-D-tyrosine hydrochloride
|
70601-63-7
|
C10H13NO3.ClH
|
|
Omethoate-d3
|
1189510-77-7
|
C5H12NO4PS
|
|
O-METHYLSTERIGMATOCYSTIN
|
17878-69-2
|
C19H14O6
|
|
2',3'-O-(Methoxymethylene)uridine
|
16628-81-2
|
C11H14N2O7
|
|
2'-O-(2-Methoxyethyl)-5-methyluridine
|
163759-49-7
|
C13H20N2O7
|
|
3’-O-Methyl-thymidine-d3
|
|
C11H16N2O5
|
|
4'-O-Methylcatechin
|
69912-75-0
|
C16H16O6
|
|
3'-O-Methylcatechin
|
60383-97-3
|
C16H16O6
|
|
4,5-O-(1-Methylethylidene)-β-D-fructopyranose
|
912456-61-2
|
C9H16O6
|
|
2'-O-(2-Methoxyethyl)guanosine
|
473278-54-5
|
C13H19N5O6
|
|
O-Methyl Atorvastatin Calcium Salt
|
887196-29-4
|
C67H68Ca2F2N4O10
|
|
|
4-[4-(4-O-Methoxymethyl-4-hydroxyphenyl)-1-piperazinyl]benzenamine-d4
|
|
C18H23N3O2
|
|
1-(4-O-Methoxymethyl-4-hydroxyphenyl)-4-(4-nitrophenyl)piperazine-d4
|
1246819-68-0
|
C18H21N3O4
|
|
4-[4-(4-O-Methoxymethyl-4-hydroxyphenyl)-1-piperazinyl]phenyl]carbamic Acid Phenyl Ester
|
1329503-19-6
|
C25H27N3O4
|
|
O’-(4-Methylumbelliferyl)-O6-acetyl-2-acetylamino-O3-(tri-O-acetyl-α-L-fucopyranosyl)-O4-
(tetra-O-acetyl-β-D-galactopyranosyl)-2-deoxy-β-D-glucopyranose
|
|
C46H57NO25
|
|
1-(4-O-Methoxymethyl-4-hydroxyphenyl)-4-(4-nitrophenyl)piperazine
|
1246819-65-7
|
C18H21N3O4
|
|
2'-O-(2-Methoxyethyl)uridine
|
223777-15-9
|
C12H18N2O7
|
|
10-O-Methoxymethyl SN-38
|
1246815-54-2
|
C24H24N2O6
|
|
2'-O-Methyl Paclitaxel
|
156413-67-1
|
C48H53NO14
|
|
4-[4-(4-O-Methoxymethyl-4-hydroxyphenyl)-1-piperazinyl]phenyl]carbamic Acid-d4 Phenyl Ester
|
1246817-73-1
|
C25H27N3O4
|
|
2'-O-(2-Methoxyethyl)cytidine
|
223777-16-0
|
C12H19N3O6
|
|
O-(4-methoxyphenyl)hydroxylamine
|
147169-98-0
|
C7H9NO2
|
|
5-O-Methylhierochin D
|
97465-82-2
|
C20H22O6
|
|
3-O-Methylducheside A
|
62218-23-9
|
C21H18O12
|
|
3-O-Methylquercetin tetraacetate
|
1486-69-7
|
C24H20O11
|
|
16-O-Methyl-14,15-didehydroisovincal
|
112237-71-5
|
C20H24N2O
|
|
3-O-Methyltagitinin F
|
110382-37-1
|
C20H26O6
|
|
3-O-Methyltirotundin
|
1021945-29-8
|
C20H30O6
|
|
o-Methyl-D-tyrosine
|
132574-59-5
|
C10H13NO3
|
|
O-(2-Methoxyisopropyl)hydroxylamine
|
103491-33-4
|
C4H11NO2
|
|
o-(Methylthio)acetophenone
|
1441-97-0
|
C9H10OS
|
|
O-Methoxycarbonyl-phenyl aMide
|
|
C9H10NO3
|
|
3-O-Methylcarbidopa
|
85933-19-3
|
C11H16N2O4
|
|
6-O-Methyl Mycophenolic Acid Methyl Ester
|
60435-90-7
|
C19H24O6
|
|
3-O-Methyl 6-Keto 17β-Estradiol 17-O-Tetrahydropyran
|
174497-42-8
|
C24H32O4
|
|
3-O-Methyl Colterol-d9
|
1346599-83-4
|
C13H21NO3
|
|
Roxithromycin impurity I
|
425365-66-8
|
C45H84N2O17
|
|
3-O-Methyl 17β-Estradiol
|
4811-74-9
|
C24H34O3
|
|
3-O-Methyl Estrone-d5 Hydrazone
|
|
C19H26N2O
|
|
5-O-(3-Methyl-2-butenyl) KaeMpferol Tri-O-MethoxyMethyl Ether
|
143724-70-3
|
C26H30O9
|
|
3-O-Methyl 6-Hydroxy-17β-estradiol
|
473882-84-7
|
C24H34O4
|
|
3-O-Methyl Colterol
|
58868-93-2
|
C13H21NO3
|
|
3-O-Methyl Estrone Hydrazone
|
105663-60-3
|
C19H26N2O
|
|
3-O-Methyl Estrone 17-(Ethanediyl Ketal)
|
28336-29-0
|
C21H28O3
|
|
3-O-Methyl Norbuprenorphine-d9
|
|
C26H37NO4
|
|
|
3-O-Methyl Estrone-d5
|
|
C19H19D5O2
|
|
3-O-Methyl 17α-Estradiol
|
3434-76-2
|
C19H26O2
|
|
6-O-Methyl Mycophenolic Acid Methyl Ester-d9
|
|
C19H24O5
|
|
3-O-Methyl 6-Keto 17β-Estradiol-d2 17-O-Tetrahydropyran
|
|
C24H32O4
|
|
3-O-Methyl 6-Hydroxy 17β-Estradiol
|
109835-83-8
|
C19H26O3
|
|
O-Methyl Malathion β-Monoacid
|
55733-40-9
|
C7H13O6PS2
|
|
O-Methyl Malathion α-Monoacid
|
91485-13-1
|
C7H13O6PS2
|
|
1,2-O-(1-Methylethylidene)-6-O-(triphenylMethyl)-β-L-arabino-hexofuranos-5-ulose OxiMe
|
|
C28H29NO6
|
|
1,2-O-(1-Methylethylidene)-6-O-(triphenylMethyl)-β-L-arabino-hexofuranos-5-ulose OxiMe 3-Acetate
|
109680-99-1
|
C30H31NO7
|